ExeVir Bio
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platform for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access. ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium.
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does ExeVir Bio use?+
ExeVir Bio uses 19 technologies including Contact Form 7, Elementor, Google Analytics.
What industry is ExeVir Bio in?+
ExeVir Bio operates in the Biotechnology industry.
Where is ExeVir Bio based?+
ExeVir Bio is headquartered in Belgium.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026